医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Expert Seminar on Anti-COVID-19 Chinese Herbal Medicine “Honee Taishen Granule” Held in Ritan, Beijing

2020年12月07日 PM04:57
このエントリーをはてなブックマークに追加


 

BEIJING

On November 26, 2020, Beijing Handian Pharmaceutical held an expert seminar on anti-COVID-19 medicine “Honee Taishen Granule” in Ritan, Beijing.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201206005083/en/

Expert Seminar on anti-COVID-19 Chinese herbal medicine “Honee Taishen Granule” held in Ritan, Beijing (Photo: Business Wire)

Expert Seminar on anti-COVID-19 Chinese herbal medicine “Honee Taishen Granule” held in Ritan, Beijing (Photo: Business Wire)

At this meeting, the company invited a number of experts from the Chinese Academy of Sciences and the Chinese Academy of Medical Sciences to discuss the current research results of “Taishen Granules” and put forward their suggestions on the future research and development direction of this drug.

The company started a long-term anti-plague research program since Ebola outbreak in 2015, and Taishen Granule comes from a reserve formula of that program. This formula is derived from an ancient prescription against Taiyin cold-dampness and stagnation lung syndrome, which is consistent with symptoms of this COVID-19 epidemic according to traditional Chinese medicine theory. The company’s scientific research team combined with epidemiological research and clinical trial experience, followed the ancient prescription dosage and technology, and finally developed this drug.

Its components can eliminate dampness and turbidity, repel foulness and remove toxin, which give it cold-dampness eliminating and antiviral effects. According to traditional Chinese medicine theory, it rectifies Taiyin cold damp constitution and restores yin-yang balance of the body, which can help patients regain immunity and prevents the virus from affecting the spleen to damage the body.

In cooperation with the Chinese Academy of Medical Sciences, the Chinese Academy of Chinese Medical Sciences and Good Laboratory Practice (GLP) certification agencies, Handian Pharmaceutical research team has carried out relevant research on pharmacology and toxicology of this product. With the gradual improvement of various studies, it is hoped that the efficacy and safety of this product can be further verified.

Unfortunately, due to the lack of COVID-19 patients in China, it is difficult to carry out clinical research on this drug. As a result, the company is seeking international cooperation to provide antiviral drugs, and conduct further clinical research.

The Ritan (which means the Temple of Sun in Chinese) used to be a sacred place for ancient Chinese people to worship the God of Sun. The “Taishen Granule” expert seminar is held here in the hope that “Taishen Granule” will act like the sun to dispel the pain and darkness brought by COVID-19 to this world.

View source version on businesswire.com: https://www.businesswire.com/news/home/20201206005083/en/

CONTACT

Xiaoteng Bai

Beijing Handian Science & Technology (Group) Co., Ltd.

Phone: +86 010 5690 3502

Related Posts Plugin for WordPress, Blogger...

同じカテゴリーの記事 

  • Study Shows House Wellness Foods’ Breakthrough Feed LP20® Can Advance the Potential of Rivers and Seas to Feed Our Emerging World
  • Otsuka and Akebia Announce Submission of New Drug Application to the FDA for Approval of Akebia’s Vadadustat
  • ARPA Computation Platform Q1 Update: Better Performance, Usability, and Next Steps
  • Hitachi Metals Launches New Web Site to Introduce Medical Fine Gauge Cable Globally for Minimally Invasive Devices
  • 中智全球宣布1亿美元成本节约承诺,为医疗行业一线员工提供支持